1Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995,3 (6) :673-682.
2Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem, 1996,271 ( 22 ): 12687-12690.
3Chen X, Kandasamy K, Srivastava RK. Differential roles of RelA(p65 ) and c- Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res, 2003,63 (5): 1059-1066.
4MacFarlane M, Harper N, Snowden RT, et al. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. Oncogene ,2002,21 (44) :6809-6818.
5Sonnemann J, Gekeler V,Sagrauske A,et al. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down- regulation. Int J Oncol,2004,25 (4): 1171-1181.
6Jacob D, Bahra M, Schumacher G,et al. Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter. Anticancer Res ,2004,24 (5 A ) :3075-3079.
7Nagane M, Pan G, Weddle JJ,et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res,2000,60(4) :847-853.
8Singh TR, Shankar S,Chen X,et al. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer Res,2003,63 (17) :5390-5400.
9Altucci L, Rossin A, Raffelsberger W, et al. Retinoic acid- induced apoptosis in leukemia cells is mediated by paracrine action of tumor- selective death ligand TRAIL. Nat Med ,2001,7( 6 ) :680-686.
10Keane MM,Rubinstein Y,Cuello M,et al. Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines. Breast Cancer Res Treat,2000,64 (2) :211-219.
8Dunne AL,Mothersill C,Robson T,et al.Radiosensitization of colon cancer cell lines by docetaxel:mechanisms of action[J].Oncol Res,2004,14(9):447-454.
9Nagao S,Fujiwara K,Oda T,et al.Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer.A pilot study[J].Gynecol Oncol,2005,96(3):805-809.
10Hill BT,Whelan RD,Shellard SA,et al.Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro[J].Invest New Drugs,1994,12(3):169-182.
